Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. ConvaTec Group Plc
  6. Summary
    CTEC   GB00BD3VFW73

CONVATEC GROUP PLC

(CTEC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
09/21/2021 09/22/2021 09/23/2021 09/24/2021 09/27/2021 Date
224(c) 223.1(c) 226.1(c) 221.2(c) 216.9(c) Last
1 464 652 1 867 225 3 056 535 1 427 422 1 793 601 Volume
0.00% -0.40% +1.34% -2.17% -1.94% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2 025 M - -
Net income 2021 129 M - -
Net Debt 2021 882 M - -
P/E ratio 2021 32,7x
Yield 2021 2,42%
Sales 2022 2 107 M - -
Net income 2022 177 M - -
Net Debt 2022 725 M - -
P/E ratio 2022 24,8x
Yield 2022 2,62%
Capitalization 4 363 M 5 981 M -
EV / Sales 2021 2,59x
EV / Sales 2022 2,42x
Nbr of Employees 9 914
Free-Float 79,8%
More Financials
Company
ConvaTec Group PLC is a United Kingdom-based medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which... 
More about the company
Ratings of ConvaTec Group Plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about CONVATEC GROUP PLC
09/23VEEVA : Says ConvaTec Picked its Clinical Data Management System for Biomarker Study in Wo..
MT
09/12CONVATEC : Moody's Upgrades ConvaTec on Restructuring's 'Material Progress'
MT
09/09CONVATEC : JPMorgan Lifts Convatec To Overweight, Boosts PT
MT
08/09CONVATEC : RBC Lowers ConvaTec To Underperform From Sector Perform, Trims PT
MT
08/02WALL STREET STOCK EXCHANGE : US stocks continue to outperform their international peers
08/02ANALYST RECOMMENDATIONS : ConvaTec, DiscoverIE, LKQ, Unite Group, WidomTree...
07/30FTSE Down, Pearson Gains After Solid 1st Half, College App Launch
DJ
07/30CONVATEC : Lifts Revenue Growth Forecast As H1 Profit Soars
MT
07/30CONVATEC : Earnings Flash (CTEC.L) CONVATEC GROUP Posts H1 Revenue $1.01B
MT
07/30CONVATEC : Earnings Flash (CTEC.L) CONVATEC GROUP Posts H1 EPS $4.20
MT
07/30CONVATEC : Interim Results for the 6 months ended 30 June 2021 30 July 2021
PU
07/30ConvaTec Group Plc Provides Earnings Guidance for the Full Year 2021
CI
07/30Convatec Group plc Reports Earnings Results for the Half Year Ended June 30, 2021
CI
07/30ConvaTec Group plc Declares interim Dividend of 1.717 Cents Per Share, in Line with the..
CI
06/21CONVATEC : Global commercial rights signed by ConvaTed Ltd for ChloraSolv, innovative woun..
PU
More news
News in other languages on CONVATEC GROUP PLC
09/12Moody's relève la note de ConvaTec en raison des "progrès significatifs" de la restruct..
01/04Georgia on my mind
01/04AVIS D'ANALYSTES DU JOUR : Adyen, Atos, Alcon, Equinor, Rémy Cointreau, Roche, Total, Yara..
2020HEATMAP STOXX EUROPE 600 : les industrielles flanchent, la distanciation sociale résiste
2020L'Euro en quarantaine
More news
Analyst Recommendations on CONVATEC GROUP PLC
More recommendations
Chart CONVATEC GROUP PLC
Duration : Period :
ConvaTec Group Plc Technical Analysis Chart | CTEC | GB00BD3VFW73 | MarketScreener
Technical analysis trends CONVATEC GROUP PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 2,17 $
Average target price 3,45 $
Spread / Average Target 59,2%
EPS Revisions
Managers and Directors
Karim Sani Nasib Bitar Chief Executive Officer & Director
Frank M. Schulkes Chief Financial Officer & Director
John David Gibson McAdam Chairman
Robert Steele EVP-Quality, Clinical & Regulatory Affairs
Donal Balfe Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
CONVATEC GROUP PLC11.04%6 082
ABBOTT LABORATORIES13.59%220 485
MEDTRONIC PLC11.00%174 982
BECTON, DICKINSON AND COMPANY1.18%72 711
HOYA CORPORATION29.36%62 143
ALIGN TECHNOLOGY, INC.35.72%57 302